Contact A Lawyer
Near You

Contact us today for a complimentary consultation with a qualified attorney near you.

Naproxen Information

Recent naproxen information has revealed that this drug may cause an increased risk of cardiovascular side effects in patients taking even the over the counter strength of this pain medication. This naproxen information was announced publicly by the FDA in December 2004 after clinical trials revealed this potential risk. The National Institute of Health initiated a drug trial in 2001 to test the effectiveness of some medications in preventing Alzheimer's disease. This study was halted after naproxen information revealed that the trial participants taking naproxen were twice as likely to suffer from heart attack or stroke as patients in the control group.

This clinical trial was testing the effectiveness of both naproxen and a similar drug called Celebrex on preventing the development of Alzheimer's in study participants. Naproxen information from this trial revealed that seventy people suffered a stroke or heart attack out of the 2,500 participants in the naproxen group. These patients were all seventy years of age or older and had been prescribed an over the counter strength of naproxen.

Naproxen has been on the market in both over-the-counter and prescription strengths since the mid-1970s. Naproxen is the generic name for this original non-steroidal anti-inflammatory drug (NSAID), and therefore all naproxen information applies to the brand name drugs Aleve, Anaprox, Naprosyn, and Naprelan. Since these pain medications were first made available almost thirty years ago, naproxen information from clinical trials has never yielded any concrete conclusions about the long term cardiovascular safety of naproxen use.

Information about Naproxen's potential to cause gastrointestinal complications in patients has, however, been well established. Product naproxen information labeling warns patients that taking naproxen may cause ulcers, intestinal bleeding and other serious complications. As a result of this naproxen information, new drugs were developed in the 1990s to effectively treat pain without these gastrointestinal risks.

These newer NSAIDs were designed to inhibit only one enzyme involved in the tissue inflammation which causes pain. Compared to naproxen information, these drugs initially appeared to have a much lower risk of serious side effects such as gastrointestinal complications. These COX-2 selective drugs have been widely prescribed as viable alternatives to naproxen and other traditional NSAIDs.

Controversy about these drugs was sparked by the recall of Vioxx, a COX-2 selective NSAID, after studies found that Vioxx patients were at an increased risk of suffering heart attack or stroke. Patients taking 400 milligrams of Celebrex, another COX-2 NSAID, have also been shown to be at risk for cardiovascular problems. Patients taking Bextra may also be twice as likely to suffer heart attack or stroke, especially after cardiac bypass surgery. Now that naproxen information has revealed similar cardiovascular risks, the safety of all NSAIDs has been called into question. Officials are currently looking into the safety of these pain medications in order to determine the exact nature of these cardiovascular risks.

For more naproxen information, please contact us to confer with a Naproxen Lawyer and learn your legal rights and options.

Contact a Naproxen Recall Lawyer

More Naproxen Resources